fbpx
  • Home
  • Study Details
Not currently enrolling

Exploring a New Treatment for Diabetic Gastroparesis

The purpose of this research study is to see if a new medication (Relamorelin) is effective for the management and treatment of Diabetic Gastroparesis. This is a Phase 3 Clinical Trial.

Age & Gender

  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive

Contact the Team

Location

Thank you for your interest, but this study is not currently enrolling.

North Carolina (Orange)

Additional Study Information

Principal Investigator

Spencer Dorn
Center for Gastrointestinal Biology and Disease

Study Type

Clinical or Medical
Interventional

Study Topics

Chronic Conditions
Diabetes
Stomach, Digestion and Gut Health
Eating, Nutrition, and Metabolism

IRB Number

17-2585

ClinicalTrials.gov

NCT03285308

logo for the North Carolina Translational and Clinical Sciences Institute
logo for UNC Health
logo for UNC School of Medicine
logo for UNC Research
Research for Me logo

Copyright © 2013-2020 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH.  This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.

Questions?

  • This email address is being protected from spambots. You need JavaScript enabled to view it.